Smartphone-Based Cardiac Rehab for Cardiovascular Disease

Recruiting in Palo Alto (17 mi)

Overseen byAmit J Shah, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Emory University

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this study is to determine if a remote cardiac or pulmonary rehabilitation program delivered via a smartphone application and regular telephone calls will lead to improved delivery of cardiac rehabilitation compared to usual care. This includes increased adherence for eligible veterans, increased program completion, improved patient outcomes as measured by functional capacity, improved patient compliance in monitoring symptoms, improved self-efficacy and knowledge in managing disease and, a decreased rate of hospitalization and re-admissions.

Eligibility Criteria

This trial is for veterans who've had a heart attack in the last year, stable chest pain, heart surgery like bypass or valve replacement, angioplasty or stenting, heart transplants, or other specific heart conditions. They must be eligible for cardiac rehab and not have uncontrolled health issues like severe diabetes or high blood pressure.

Inclusion Criteria

I have had a heart or heart-lung transplant.

My chest pain is stable and not worsening.

You have a diagnosis from a specific doctor referred for this study.

+5 more

Exclusion Criteria

I do not have a fever or any sudden illness.

I have symptoms of heart failure that affect my daily activities.

I have a condition that affects blood flow to my limbs and prevents me from exercising.

+12 more

Participant Groups

The study tests if a smartphone app and phone calls can help deliver better cardiac rehabilitation at home compared to usual care. It looks at whether patients stick with the program better, manage their symptoms well, learn more about their condition, and if it reduces hospital visits.

3Treatment groups

Experimental Treatment

Active Control

Group I: Pulmonary Rehabilitation - Movn ProgramExperimental Treatment1 Intervention

Participants with stable chronic obstructive pulmonary disease (COPD) or hospitalized with an acute exacerbation of COPD will undergo an in-home pulmonary rehabilitation program.

Group II: Cardiac Rehabilitation - Movn ProgramExperimental Treatment1 Intervention

Participants with coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) who are eligible for cardiac rehabilitation will undergo an in-home program.

Group III: Traditional Cardiac RehabilitationActive Control1 Intervention

Participants enrolled in a facility's traditional cardiac rehabilitation program will be seen at baseline and during a 12 and 24 week follow-up visit.